176 related articles for article (PubMed ID: 2693029)
101. Secretion of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes: systematic review and meta-analysis of clinical studies.
Calanna S; Christensen M; Holst JJ; Laferrère B; Gluud LL; Vilsbøll T; Knop FK
Diabetes Care; 2013 Oct; 36(10):3346-52. PubMed ID: 24065842
[TBL] [Abstract][Full Text] [Related]
102. Factors Related to Blood Intact Incretin Levels in Patients with Type 2 Diabetes Mellitus.
Yoo S; Yang EJ; Koh G
Diabetes Metab J; 2019 Aug; 43(4):495-503. PubMed ID: 30877705
[TBL] [Abstract][Full Text] [Related]
103. Insulin secretion induced by glucose-dependent insulinotropic polypeptide requires phosphatidylinositol 3-kinase γ in rodent and human β-cells.
Kolic J; Spigelman AF; Smith AM; Manning Fox JE; MacDonald PE
J Biol Chem; 2014 Nov; 289(46):32109-32120. PubMed ID: 25288806
[TBL] [Abstract][Full Text] [Related]
104. Regular low-calorie sweetener consumption is associated with increased secretion of glucose-dependent insulinotropic polypeptide.
Chia CW; Shardell M; Gravenstein KS; Carlson OD; Simonsick EM; Ferrucci L; Egan JM
Diabetes Obes Metab; 2018 Sep; 20(9):2282-2285. PubMed ID: 29687583
[TBL] [Abstract][Full Text] [Related]
105. Consumption of nutrients and insulin resistance suppress markers of bone turnover in subjects with abdominal obesity.
Fuglsang-Nielsen R; Rakvaag E; Vestergaard P; Hartmann B; Holst JJ; Hermansen K; Gregersen S; Starup-Linde J
Bone; 2020 Apr; 133():115230. PubMed ID: 31954199
[TBL] [Abstract][Full Text] [Related]
106. Comparison of the metabolic effects of mixed meal and standard oral glucose tolerance test on glucose, insulin and C-peptide response in healthy, impaired glucose tolerance, mild and severe non-insulin-dependent diabetic subjects.
Marena S; Montegrosso G; De Michieli F; Pisu E; Pagano G
Acta Diabetol; 1992; 29(1):29-33. PubMed ID: 1520903
[TBL] [Abstract][Full Text] [Related]
107. Polyunsaturated fatty acids augment insulin secretion.
Lardinois CK; Starich GH; Mazzaferri EL; DeLett A
J Am Coll Nutr; 1987 Dec; 6(6):507-15. PubMed ID: 3320156
[TBL] [Abstract][Full Text] [Related]
108. Impact of dipeptidyl peptidase-4 inhibitors on glucose-dependent insulinotropic polypeptide in type 2 diabetes mellitus: a systematic review and meta-analysis.
Chai S; Zhang R; Carr RD; Deacon CF; Zheng Y; Rajpathak S; Chen J; Yu M
Front Endocrinol (Lausanne); 2023; 14():1203187. PubMed ID: 37635974
[TBL] [Abstract][Full Text] [Related]
109. The study of metabolic improvement by nutritional intervention controlling endogenous GIP (Mini Egg study): a randomized, cross-over study.
Sakane N; Osaki N; Takase H; Suzuki J; Suzukamo C; Nirengi S; Suganuma A; Shimotoyodome A
Nutr J; 2019 Sep; 18(1):52. PubMed ID: 31477157
[TBL] [Abstract][Full Text] [Related]
110. The naturally occurring GIP(1-30)NH2 is a GIP receptor agonist in humans.
Krogh LSL; Henriksen K; Stensen S; Skov-Jeppesen K; Bergmann NC; Størling J; Rosenkilde MM; Hartmann B; Holst JJ; Gasbjerg LS; Knop FK
Eur J Endocrinol; 2023 Jan; 188(1):. PubMed ID: 36651162
[TBL] [Abstract][Full Text] [Related]
111. Circulating total and H-specific GDF15 levels are elevated in subjects with MASLD but not in hyperlipidemic but otherwise metabolically healthy subjects with obesity.
Boutari C; Stefanakis K; Simati S; Guatibonza-García V; Valenzuela-Vallejo L; Anastasiou IA; Connelly MA; Kokkinos A; Mantzoros CS
Cardiovasc Diabetol; 2024 May; 23(1):174. PubMed ID: 38762719
[TBL] [Abstract][Full Text] [Related]
112. Effects of a large supper on glucose levels the following morning in patients with type 2 diabetes.
Arauz-Pacheco C; Clements G; Cercone S; Brinkley L; Raskin P
J Diabetes Complications; 1998; 12(2):61-4. PubMed ID: 9559482
[TBL] [Abstract][Full Text] [Related]
113. Effects of GIP on regional blood flow during normoglycemia and hyperglycemia in anesthetized rats.
Gao X; Lindqvist A; Sandberg M; Groop L; Wierup N; Jansson L
Physiol Rep; 2018 Apr; 6(8):e13685. PubMed ID: 29673130
[TBL] [Abstract][Full Text] [Related]
114. The impact of insulin administration during the mixed meal tolerance test.
Besser RE; Jones AG; McDonald TJ; Shields BM; Knight BA; Hattersley AT
Diabet Med; 2012 Oct; 29(10):1279-84. PubMed ID: 22435709
[TBL] [Abstract][Full Text] [Related]
115. Dose-dependent efficacy of the glucose-dependent insulinotropic polypeptide (GIP) receptor antagonist GIP(3-30)NH
Gasbjerg LS; Bari EJ; Stensen S; Hoe B; Lanng AR; Mathiesen DS; Christensen MB; Hartmann B; Holst JJ; Rosenkilde MM; Knop FK
Diabetes Obes Metab; 2021 Jan; 23(1):68-74. PubMed ID: 32886401
[TBL] [Abstract][Full Text] [Related]
116. No effect of gliclazide on gastric inhibitory polypeptide (GIP) in type II diabetes.
Scott RS; Donnelly T
Diabetes Res Clin Pract; 1987; 3(3):175-8. PubMed ID: 3595434
[TBL] [Abstract][Full Text] [Related]
117. Obesity-associated Blunted Subcutaneous Adipose Tissue Blood Flow After Meal Improves After Bariatric Surgery.
Saari T; Koffert J; Honka H; Kauhanen S; U-Din M; Wierup N; Lindqvist A; Groop L; Virtanen KA; Nuutila P
J Clin Endocrinol Metab; 2022 Jun; 107(7):1930-1938. PubMed ID: 35363252
[TBL] [Abstract][Full Text] [Related]
118. Glucose-Dependent Insulinotropic Polypeptide (GIP) Reduces Bone Resorption in Patients With Type 2 Diabetes.
Christensen MB; Lund AB; Jørgensen NR; Holst JJ; Vilsbøll T; Knop FK
J Endocr Soc; 2020 Sep; 4(9):bvaa097. PubMed ID: 32904711
[TBL] [Abstract][Full Text] [Related]
119. The postprandial response of gastric inhibitory polypeptide to various dietary fats in man.
Lardinois CK; Starich GH; Mazzaferri EL
J Am Coll Nutr; 1988 Jun; 7(3):241-7. PubMed ID: 3392357
[TBL] [Abstract][Full Text] [Related]
120. Metabolic tests to determine risk for type 1 diabetes in clinical trials.
Greenbaum CJ; Buckingham B; Chase HP; Krischer J;
Diabetes Metab Res Rev; 2011 Sep; 27(6):584-9. PubMed ID: 21488143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
